PRDM9 and prostate cancer: In Myc-driven prostate cancers, EZH2 histone methyltransferase expression is induced and causes the repression of Interferon gamma receptor 1, with consequent loss of tumor suppressor signaling and reduced apoptosis due to the activation of this receptor.